Landos Biopharma, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-0.57 | 35.84 | -101.58% | -4.83 | -88.3% |
| P/S |
|
1.8 | 127.81 | -98.59% |
|
|
| P/BV |
|
0.71 | 254.49 | -99.72% |
|
|
| P/FCF |
|
-0.61 | -175.22 | -99.65% |
|
|
| Ev/Ebitda |
|
0.66 | -27.35 | -102.42% |
|
|
| Ev/S |
|
-0.83 | 536.01 | -100.16% |
|
|
| Ev/FCF |
|
0.73 | -282.71 | -100.26% |
|
|
| E/P |
|
-1.77 | 0.0223 | -8028.51% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-126.26 | -366.8 | -65.58% | -127.06 | -0.63% |
| ROE |
|
-69 | 104.34 | -166.13% |
|
|
| ROA |
|
-57.66 | -2.2 | 2521.09% |
|
|
| ROIC |
|
-53.23 | 1.17 | -4634.29% |
|
|
| ROS |
|
-121.86 | -291.82 | -58.24% |
|
|
| ROCE |
|
-129.28 | 3.23 | -4107.72% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0012 | 0.97 | -100.12% | -0.0011 | +12.37% |
| Nеt Debt/Ebitda |
|
1.65 | 1.05 | 57.32% |
|
|
| Debt/Ratio |
|
0.00071 | 0.18 | -99.6% |
|
|
| Debt/Equity |
|
0.2 | 1.59 | -87.64% |
|
|
| Debt/Net Income |
|
-0.0012 | -1.48 | -99.92% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.55 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8 | -100% | ||
| DSI |
|
0 | 0.22 | -100% |
|
|
| Average dividend growth |
|
0 | 1.88 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.52 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.01 | -100% |
|
|
| Difference from average difference in sector |
|
-0.55 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -90.69 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
74.82 | -121.55 | -161.55% | ||
| Growth impulse Net Income in 5 years |
|
62.48 | -104.46 | -159.81% | ||
| Growth impulse FCF in 5 years |
|
104.77 | -121.68 | -186.1% | ||
| Growth impulse EPS in 5 years |
|
744.44 | -97.03 | -867.23% |
IP Score
4.52/10
